Zealand Pharma A/S (ZLDPF)
73.75
-3.25
(-4.22%)
USD |
OTCM |
Dec 30, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.184B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -27.95% |
| Valuation | |
| PE Ratio | 5.307 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.754 |
| Price to Book Value | 2.172 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0268 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 74.12% |
Profile
| Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark. |
| URL | http://www.zealandpharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zealand |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Feb. 19, 2026 |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark. |
| URL | http://www.zealandpharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zealand |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Feb. 19, 2026 |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |